These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16981557)

  • 1. [Medical economics of antihypertensive agents].
    Yamazaki T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():285-8. PubMed ID: 16981557
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical economics of hypertension therapy].
    Yamazaki T
    Nihon Rinsho; 2008 Aug; 66(8):1601-4. PubMed ID: 18700564
    [No Abstract]   [Full Text] [Related]  

  • 3. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
    Rorive G; Delporte JP
    Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, a health economics perspective.
    Alcocer L; Cueto L
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):147-55. PubMed ID: 19124418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics of hypertension control: basic principles of economic evaluation.
    Wilson TW; Chockalingam A; Quest DW
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():S19-22. PubMed ID: 8868039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blockers: impact on costs of care.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacotherapy of hypertension. How much can safely be saved?].
    Anlauf M
    MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fully possible to reduce the costs of hypertension treatment].
    Wettermark B; Angman A; Hjemdahl P
    Lakartidningen; 2009 Jun 3-9; 106(23):1558-62. PubMed ID: 19583013
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cost-effectiveness of treatment of high blood pressure with losartan in Denmark].
    Keiding H; Hildebrandt P; Burke T; Carides GW
    Ugeskr Laeger; 2006 Oct; 168(42):3623-6. PubMed ID: 17069726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health economic issues and the future treatment and management of hypertension.
    Giles TD
    AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 12. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
    Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L
    Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623
    [No Abstract]   [Full Text] [Related]  

  • 13. [The cost/benefit of antihypertensive therapy].
    Pessina AC
    Ann Ital Med Int; 1995 Oct; 10 Suppl():96S-98S. PubMed ID: 8562277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit of treating hypertension.
    Jönsson BG
    J Hypertens Suppl; 1994 Dec; 12(10):S65-70. PubMed ID: 7769494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive treatment. Benefits and costs].
    Jensen HA; Svendsen TL
    Ugeskr Laeger; 1993 Jan; 155(2):118-20. PubMed ID: 8421861
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost as a factor in the treatment of hypertension.
    Dart RA
    Contemp Intern Med; 1995 Feb; 7(2):10-4. PubMed ID: 10150334
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.
    Caro JJ; Lee K
    Curr Hypertens Rep; 2002 Dec; 4(6):418. PubMed ID: 12419167
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacoeconomic issues in antihypertensive treatment].
    Saito I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():271-5. PubMed ID: 16981554
    [No Abstract]   [Full Text] [Related]  

  • 19. Moderately elevated blood pressure. A report from SBU, the Swedish Council on Technology Assessment in Health Care.
    J Intern Med Suppl; 1995; 737():1-225. PubMed ID: 9043531
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost effective analyses in the treatment of high blood pressure.
    Fletcher A
    J Hum Hypertens; 1992 Dec; 6(6):437-45. PubMed ID: 1296007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.